Cargando…

Results from a national treatment database – does it matter which ART combination is prescribed in the real world?

INTRODUCTION: Clinical trials frequently show differences in viral load (VL) response between antiretroviral therapy (ART) regimes. Patterns of prescribing vary from country to country (Mocroft et al. Infection 2014 Jun 6 [epub ahead of print]), and are likely to vary between individual clinics. Sco...

Descripción completa

Detalles Bibliográficos
Autores principales:	Scott, Gordon, Wallace, Lesley
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International AIDS Society 2014
Materias:	Poster Sessions – Abstract P082
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224830/ https://www.ncbi.nlm.nih.gov/pubmed/25394118 http://dx.doi.org/10.7448/IAS.17.4.19614

Ejemplares similares

USO DE APLICATIVO MULTIPLATAFORMA DE MENSAGENS EM PANDEMIA COVID 19
por: Bolonhez, Jaqueline Forestieri, et al.
Publicado: (2021)

Tolérance du vaccin anti-COVID19 chez les patients drépanocytaires adultes
por: Corbasson, A., et al.
Publicado: (2021)

SÍNDROME INFLAMATÓRIA MULTISSISTÊMICA DO ADULTO COMO IMPORTANTE DIAGNÓSTICO DIFERENCIAL EM PACIENTES GRAVES PÓS COVID-19: UM RELATO DE CASO
por: Ramos, Alex Pereira, et al.
Publicado: (2022)

Quels sont les facteurs liés au vécu douloureux des patients atteints de rhumatisme inflammatoire chronique pendant la pandémie de la COVID-19 ?
por: Eljoumani, T., et al.
Publicado: (2022)

Severe birth defects in children perinatal exposed to HIV from a “real-world” setting: Infectious Diseases National Institute, Bucharest, Romania
por: Maria Tudor, Ana
Publicado: (2014)

HIV test: which is your best? A National survey on testing preferences among MSM in Italy
por: Mattioli, Sandro, et al.
Publicado: (2014)

No difference in persistence to treatment with atazanavir or darunavir in HIV patients in a real-world setting
por: Farr, Amanda M, et al.
Publicado: (2014)

Real-world medication persistence with single versus multiple tablet regimens for HIV-1 treatment
por: Sweet, Donna, et al.
Publicado: (2014)

Patients' description and resource use in COVID-19 hospitalized patients based on a French claims real-world database
por: Leboucher, C., et al.
Publicado: (2022)

Safety of darunavir/ritonavir (DRV/r) in HIV-1-infected DRV/r-experienced and -naïve patients: analysis of data in the real-world setting in Italy
por: Antinori, Andrea, et al.
Publicado: (2014)

Antiretroviral therapy (ART) management of Low-Level Viremia in Taiwan (ALLEVIATE)
por: Cheng, Chien-Yu, et al.
Publicado: (2014)

Attitudes and beliefs towards early ART initiation in MSM with primary HIV infection
por: Parsons, Victoria, et al.
Publicado: (2014)

A retrospective observational study of low-level viraemia and its immunological and virological significance: which outcome to expect
por: Silva, Joana, et al.
Publicado: (2014)

Efficacy of a dual therapy based on darunavir/ritonavir and etravirine in ART-experienced patients
por: Ignacio Bernardino, Jose, et al.
Publicado: (2014)

ART management in children perinatally infected with HIV from mothers who experience behavioural changes in Romania
por: Märdärescu, Mariana, et al.
Publicado: (2014)

Early changes in coagulation but not inflammatory biomarkers under intermittent ART: the randomized ANRS 106 WINDOW trial
por: Gallien, Sébastien, et al.
Publicado: (2014)

Factors associated with HPV-DNA clearance in a cohort of HIV-positive patients: role of cART and gender
por: Suardi, Elisa, et al.
Publicado: (2014)

Time on drug analysis based on real life data
por: Schülter, Eugen, et al.
Publicado: (2014)

Outcomes of initial antiretroviral treatment (ART) among recently diagnosed HIV patients in HIV-TR cohort, 2011–2012
por: Korten, Volkan, et al.
Publicado: (2014)

The importance of viral blips and duration of therapy initiated in primary infection in maintaining viral control after stopping cART
por: Fidler, Sarah, et al.
Publicado: (2014)

The impact of nevirapine- versus protease inhibitor-based regimens on virological markers of HIV-1 persistence during seemingly suppressive ART
por: Kiselinova, Maja, et al.
Publicado: (2014)

High rates of viral suppression in a cohort of HIV-positive adults receiving ART in Ethiopian health centers irrespective of concomitant tuberculosis
por: Reepalu, Anton, et al.
Publicado: (2014)

Epi-aortic lesions, pathologic FMD, endothelial activation and inflammatory markers in advanced naïve HIV-infected patients starting ART therapy
por: Bellacosa, Chiara, et al.
Publicado: (2014)

Relationship between innate immunity, soluble markers and metabolic-clinical parameters in HIV+ patients ART treated with HIV-RNA<50 cp/mL
por: Dentone, Chiara, et al.
Publicado: (2014)

An observational comparison of first-line combination antiretroviral treatment (cART) with 2NRTI and ATV/r or DRV/r in HIV-infected patients in Italy
por: Cozzi-Lepri, Alessandro, et al.
Publicado: (2014)

Using social network methods to reach out-of-care or ART-nonadherent HIV+ injection drug users in Russia: addressing a gap in the treatment cascade
por: Amirkhanian, Yuri, et al.
Publicado: (2014)

AIDS defining opportunistic infections in patients with high CD4 counts in the combination antiretroviral therapy (cART) era: things ain't what they used to be
por: Gisler, Valentin, et al.
Publicado: (2014)

Cost/efficacy analysis of preferred Spanish AIDS study group regimens and the dual therapy with LPV/r+3TC for initial ART in HIV infected adults
por: Gatell, Josép M, et al.
Publicado: (2014)

Intermittent viraemia and immune reconstitution in patients with more than 10–15 years of antiretroviral therapy: baseline values still matter
por: Erdbeer, Gesa, et al.
Publicado: (2014)

144-week outcomes of lopinavir/ritonavir (LPV/r)-based first-line ART in 1,409 HIV-infected patients: data from the German STAR/STELLA cohort
por: Wolf, Eva, et al.
Publicado: (2014)

CNS safety at 48-week of switching to ATV/r plus 3TC or two nucleos(t)ides in HIV-suppressed patients on stable ART: the SALT neurocognitive sub-study
por: Pérez Valero, Ignacio, et al.
Publicado: (2014)

Central nervous system penetration-effectiveness rank does not reliably predict neurocognitive impairment in HIV-infected individuals
por: Libertone, Raffaella, et al.
Publicado: (2014)

Attitudes of serodiscordant couples towards antiretroviral-based HIV prevention strategies in Kenya: a qualitative study
por: Fowler, Nikola, et al.
Publicado: (2014)

The potential impact of new national guidance on primary prevention of cardiovascular disease in people living with HIV
por: Ahmed, Nadia, et al.
Publicado: (2014)

Reducing turnaround time for laboratory test results does not improve retention of stable HIV-infected adults on POV program: experience from Uganda
por: Maselle, Edna, et al.
Publicado: (2014)

Age-related COVID-19 vaccination patterns during pregnancy using the cerner real-world data: a large national cohort
por: O'Brien, Devon, et al.
Publicado: (2023)

Telaprevir or boceprevir in HIV/HCV-1 co-infected patients in a real-life setting. Interim analysis (24 weeks). COINFECOVA-SEICV study
por: Minguez, Carlos, et al.
Publicado: (2014)

Less frequent follow-up in routine care than in trials does not impact resistance selection in patients failing DRV/r or ATV/r first line treatment
por: Marcelin, Anne-Genevieve, et al.
Publicado: (2014)

ELDER ABUSE BY FAMILY CAREGIVER: DOES COGNITIVE IMPAIRMENT REALLY MATTER?
por: Yan, Elsie
Publicado: (2019)

Gag drug resistance mutations in HIV-1 subtype C patients, failing a protease inhibitor inclusive treatment regimen, with detectable lopinavir levels
por: Kelly Pillay, Sameshnee, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_4ihldhikqsg57jb3rlbhdj82tr